{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:17:07Z","timestamp":1773339427324,"version":"3.50.1"},"reference-count":16,"publisher":"Scientific Scholar","content-domain":{"domain":["ijmr.org.in"],"crossmark-restriction":true},"short-container-title":["Indian J Med Res"],"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Sickle cell disease poses a significant healthcare burden across several regions and states in India. We present findings from a sickle cell anaemia registry in the State of Jharkhand, a tribal predominant state situated in Eastern India, to provide an insight into the clinico-epidemiological profile and need-based management of sickle cell anaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sickle cell disease Registry at Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand was started in the year 2022 and it has 334 sickle cell disease patients recruited over two and a half years. This clinical research provides systematically captured comprehensive data of sickle cell anaemia patients with\n                      <jats:italic>HbSS<\/jats:italic>\n                      genotype, including demographics, clinical presentation, laboratory findings, treatment modalities, complications, and their outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinical manifestations varied from mild to severe, with the most common presentation being vaso-occlusive crises (n=257, 94.5%). A significant proportion of patients required blood transfusion n=260, (95.6%). Hydroxyurea the mainstay of treatment, was taken regularly by 136, (50%) of patients, whereas n=68, 25% were irregularly taking hydroxyurea medication and n= 68, 25% never took it. Regular intake of hydroxyurea therapy was significantly associated with reduction in pain crises and a decreased need for blood transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation and conclusions<\/jats:title>\n                    <jats:p>Establishment of hydroxyurea monitoring units, monitoring of blood transfusion through appropriate investigations, increased utilisation of iron chelation therapy, and identification of patients with increased stroke risk can lead to improved patient care, escalated awareness and reduced rate of hospitalisation in sickle cell disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/ijmr_1644_2025","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T16:26:12Z","timestamp":1772382372000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sickle cell disease in Jharkhand: A registry-based evaluation of disease burden and healthcare needs"],"prefix":"10.25259","volume":"163","author":[{"given":"Anupa","family":"Prasad","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"},{"name":"Department of Genetics and Genomics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aradhana","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"},{"name":"Department of Genetics and Genomics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genomics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha Kumar","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Shakya","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genomics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genomics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine and Advanced Blood Centre, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun Vincent","family":"Kisku","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genomics, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi Tuhin","family":"Guria","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"10.25259\/IJMR_1644_2025\/ref-1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMc1706325","article-title":"Sickle cell disease","volume":"377","author":"Piel","year":"2017","journal-title":"N Engl J Med."},{"key":"10.25259\/IJMR_1644_2025\/ref-3","doi-asserted-by":"crossref","first-page":"S398405","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: A neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med."},{"key":"10.25259\/IJMR_1644_2025\/ref-6","doi-asserted-by":"publisher","first-page":"102873","DOI":"10.1016\/j.bcmd.2024.102873","article-title":"Sickle cell disease in Indian tribal population: Findings of a multi-center Indian SCD registry","volume":"109","author":"Sharma","year":"2024","journal-title":"Blood Cells Mol Dis."},{"key":"10.25259\/IJMR_1644_2025\/ref-7","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/S2352-3026(24)00109-1","article-title":"Sickle cell disease in India: Current status and progress","volume":"11","author":"Jain","year":"2024","journal-title":"Lancet Haematol."},{"key":"10.25259\/IJMR_1644_2025\/ref-8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1182\/asheducation-2017.1.525","article-title":"Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease","volume":"2017","author":"Telfer","year":"2017","journal-title":"Hematology Am SocHematolEduc Program."},{"key":"10.25259\/IJMR_1644_2025\/ref-10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.18203\/2394-6040.ijcmph20161399","article-title":"Initial outcomes of a comprehensive care model for sickle cell disease among a tribal population in rural western India","volume":"3","author":"Desai","year":"2016","journal-title":"Int J Community Med Public Health."},{"key":"10.25259\/IJMR_1644_2025\/ref-11","doi-asserted-by":"publisher","first-page":"e74489","DOI":"10.7759\/cureus.74489","article-title":"A retrospective analysis of demographics, clinical features, and treatment patterns in sickle cell disease patients at a tertiary healthcare center of North East India","volume":"16","author":"Dutta","year":"2024","journal-title":"Cureus."},{"key":"10.25259\/IJMR_1644_2025\/ref-12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s13312-012-0217-z","article-title":"Sickle cell anemia from central India: A retrospective analysis","volume":"49","author":"Jain","year":"2012","journal-title":"Indian Pediatr."},{"key":"10.25259\/IJMR_1644_2025\/ref-13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/BF02730713","article-title":"Sickle cell disease in central India","volume":"71","author":"Patel","year":"2004","journal-title":"Indian J Pediatr."},{"key":"10.25259\/IJMR_1644_2025\/ref-14","doi-asserted-by":"publisher","first-page":"8584","DOI":"10.1038\/s41598-024-58328-9","article-title":"Multi-center study on mortality in children, and adults with sickle cell anemia-risk factors and causes of death","volume":"14","author":"Alkindi","year":"2024","journal-title":"Sci Rep."},{"key":"10.25259\/IJMR_1644_2025\/ref-15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13023-021-01781-w","article-title":"Hydroxyurea and blood transfusion therapy for sickle cell disease in South Asia: Inconsistent treatment of a neglected disease","volume":"16","author":"Darshana","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"10.25259\/IJMR_1644_2025\/ref-16","first-page":"48","article-title":"Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: A randomized, double-blind study of the dose-response relationship","volume":"122","author":"Silliman","year":"1993","journal-title":"J Lab Clin Med."},{"key":"10.25259\/IJMR_1644_2025\/ref-17","doi-asserted-by":"publisher","first-page":"10760296211047230","DOI":"10.1177\/10760296211047230","article-title":"Iron chelation reduces DNA damage in sickle cell anemia","volume":"27","author":"Al-Khateeb","year":"2021","journal-title":"Clin Appl Thromb Hemost."},{"key":"10.25259\/IJMR_1644_2025\/ref-18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/bjh.14575","article-title":"How we manage iron overload in sickle cell patients","volume":"177","author":"Coates","year":"2017","journal-title":"Br J Haematol."},{"key":"10.25259\/IJMR_1644_2025\/ref-19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/03630269.2024.2340685","article-title":"Genetic variants associated with the risk of stroke in sickle cell anemia: Systematic review and meta-analysis","volume":"48","author":"Kumari","year":"2024","journal-title":"Hemoglobin."},{"key":"10.25259\/IJMR_1644_2025\/ref-20","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1212\/WNL.0000000000004832","article-title":"Silent cerebral infarct definitions and full-scale IQ loss in children with sickle cell anemia","volume":"90","author":"Choudhury","year":"2018","journal-title":"Neurology."}],"container-title":["The Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ijmr.org.in\/sickle-cell-disease-in-jharkhand-a-registry-based-evaluation-of-disease-burden-and-healthcare-needs\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ijmr.org.in\/sickle-cell-disease-in-jharkhand-a-registry-based-evaluation-of-disease-burden-and-healthcare-needs\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:17:03Z","timestamp":1773303423000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijmr.org.in\/sickle-cell-disease-in-jharkhand-a-registry-based-evaluation-of-disease-burden-and-healthcare-needs\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":16,"alternative-id":["10.25259\/IJMR_1644_2025"],"URL":"https:\/\/doi.org\/10.25259\/ijmr_1644_2025","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"article-number":"88"}}